Delivery Order SPE2DB25D7056-SPE2DB25FTMRG
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops in 70-count units, with a firm fixed price of $2,945.98 and an ultimate completion date of June 13, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops, a prescription medication. The contract is a firm fixed-price, non-set-aside contract with a ceiling value of $2,477.85 and a period of performance through June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Refresh Plus 0.5% eye drops, a critical medical commodity, to support military treatment programs and facilities worldwide. The contract has a ceiling value of $21,699.74 and is scheduled for completion by September 26, 2024. The contract is a firm fixed-price, delivery order type...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a firm fixed price, a ceiling value of $1,014.55, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a ceiling value of $1,206.20 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution network, will provide these medical supplies to support military treatment...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Refresh Plus 0.5% eye drops, with an ultimate completion date of July 2, 2025 and a ceiling value of $2,675.45. The contract is not set-aside and is funded by the DLA, which is a defense agency. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Refresh Plus 0.5% eye drops. The contract has a firm fixed price of $1,303.65 and an ultimate completion date of June 12, 2025. It is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Refresh Plus 0.5% eye drops, with a ceiling value of $1,656.53 and a period of performance through June 13, 2025. This delivery order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Refresh Plus 0.5% eye drops, a prescription medication, with a ceiling value of $2,824.79 and a period of performance through May 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a medical product, with a ceiling value of $1,458.72 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, which means Amerisourcebergen will provide the specified product at a...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMRGDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Refresh Plus 0.5% eye drops. The contract has a firm fixed price, a ceiling value of $3,763.95, and a performance period through June 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 6/27/25 |